Genmab — April 2019

[iboge]

En dag i plus, 1 kr. pr. aktie, HURRA.

[iboge]

Nu, 1,5 kr,

[E_L]

well we closed the february gap and found a few buyers there and formed a tiny hammer -not that that means a lot with this stock... Let's see if it can hold in the next few days

[Plimsoller]

God morgen

[Parasitism]

God morgen

[Bulder]

Recepttal?

[bibob]

God morgen.

[bibob]

Fik vi ikke dem før påske Bulder. ??

[polle1]

God morgen og god dag

[jkj]

nej det gjorde vi ikke, vi mangler dem for at regne den nøjagtige rabat ud.

[E_L]

"Based on the promising preliminary results and the large interest in treating RRMM patients with melflufen together with daratumumab, Oncopeptides is planning to start a phase 3 study with this combination later this year."
https://finance.yahoo.com/news/oncopeptides-provides-guidance-patient-recruitment-054600203.html

[Sukkeralf]

Exciting to see isatuximab data - and how Sanofi will behave when (if) it gets approved:

[Sukkeralf]

https://iplanner.asco.org/am2019/#/

[E_L]

well, they are already looking for an
Associate Director, Isatuximab Global Marketing, Multiple Myeloma https://www.linkedin.com/jobs/view/associate-director-isatuximab-global-marketing-multiple-myeloma-at-sanofi-1228850133?trk=guest_job_details_job_title

[JohnW]

Hvilken behandlingslinie søges Isatuximab godkendt til?

[kkjoel]

Er recepttallene virkelig ikke kommet endnu?

[kkjoel]

Der plejer altid at være en der er flink til at offentliggøre dem herinde...

[E_L]

@JohnW - it isn't yet , it does have orphan status though in US and Europe. and i think i saw it on the agenda for this weeks EMA meeting for the combo with pom/dex

[JohnW]

Ok, thanks E L.

[Vitus]

Uha uha....enorm ringe tillid til og tro på Genmab aktien. Hvis troen er lige så stor som mange herinde giver udtryk for, så kan jeg ikke forstå, at den ikke stiger i raketfart ....